BR112014028396A2 - processo de isolamento/purificação de célula de tumor e métodos para uso da mesma - Google Patents

processo de isolamento/purificação de célula de tumor e métodos para uso da mesma

Info

Publication number
BR112014028396A2
BR112014028396A2 BR112014028396A BR112014028396A BR112014028396A2 BR 112014028396 A2 BR112014028396 A2 BR 112014028396A2 BR 112014028396 A BR112014028396 A BR 112014028396A BR 112014028396 A BR112014028396 A BR 112014028396A BR 112014028396 A2 BR112014028396 A2 BR 112014028396A2
Authority
BR
Brazil
Prior art keywords
methods
tumor cell
purification process
cell isolation
isolation
Prior art date
Application number
BR112014028396A
Other languages
English (en)
Inventor
Hallquist Allan
Presant Cary
Perrée Mathieu
Original Assignee
Diatech Oncology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diatech Oncology filed Critical Diatech Oncology
Publication of BR112014028396A2 publication Critical patent/BR112014028396A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/24—Methods of sampling, or inoculating or spreading a sample; Methods of physically isolating an intact microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/557—Immunoassay; Biospecific binding assay; Materials therefor using kinetic measurement, i.e. time rate of progress of an antigen-antibody interaction
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2527/00—Culture process characterised by the use of mechanical forces, e.g. strain, vibration
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells
BR112014028396A 2012-05-15 2013-03-14 processo de isolamento/purificação de célula de tumor e métodos para uso da mesma BR112014028396A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261647248P 2012-05-15 2012-05-15
PCT/US2013/031300 WO2013172955A1 (en) 2012-05-15 2013-03-14 Tumor cell isolation/purification process and methods for use thereof

Publications (1)

Publication Number Publication Date
BR112014028396A2 true BR112014028396A2 (pt) 2018-05-29

Family

ID=49584132

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014028396A BR112014028396A2 (pt) 2012-05-15 2013-03-14 processo de isolamento/purificação de célula de tumor e métodos para uso da mesma

Country Status (17)

Country Link
US (2) US20150160193A1 (pt)
EP (1) EP2850434A4 (pt)
JP (1) JP2015517662A (pt)
KR (1) KR20150035537A (pt)
CN (1) CN104704368A (pt)
AU (1) AU2013263337A1 (pt)
BR (1) BR112014028396A2 (pt)
CA (1) CA2873180A1 (pt)
CO (1) CO7240391A2 (pt)
CR (1) CR20140575A (pt)
HK (1) HK1208727A1 (pt)
IL (1) IL235709A0 (pt)
IN (1) IN2014DN09582A (pt)
MX (1) MX2014013939A (pt)
SG (1) SG11201407497TA (pt)
TW (1) TW201409029A (pt)
WO (1) WO2013172955A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9476871B2 (en) 2012-05-02 2016-10-25 Diatech Oncology Llc System and method for automated determination of the relative effectiveness of anti-cancer drug candidates
EP2953544B1 (en) * 2013-02-06 2019-05-08 Intervet Inc. System for determining antibiotic effectiveness in respiratory diseased using auscultation analysis
MX2016007972A (es) 2013-12-17 2016-10-28 Genentech Inc Metodos para tratar canceres con antagonistas de union al eje pd-1 y taxanos.
AU2016280070B2 (en) 2015-06-17 2022-09-15 Genentech, Inc. Methods of treating locally advanced or metastatic breast cancers using PD-1 axis binding antagonists and taxanes
KR102445255B1 (ko) 2016-03-02 2022-09-22 에자이 알앤드디 매니지먼트 가부시키가이샤 에리불린-기반 항체-약물 콘주게이트 및 사용 방법
TWI662130B (zh) * 2018-09-21 2019-06-11 國立臺灣大學 分離循環癌細胞之方法
CN111019897B (zh) * 2019-02-14 2023-08-11 中山大学孙逸仙纪念医院 人良性叶状肿瘤细胞系glk-1010及其应用
CN111019898B (zh) * 2019-02-14 2023-07-21 中山大学孙逸仙纪念医院 人恶性叶状肿瘤细胞系hjp-0320及其应用
CN111019899B (zh) * 2019-02-14 2023-08-04 中山大学孙逸仙纪念医院 人恶性叶状肿瘤细胞系lj-0429及其应用
CN113466417B (zh) * 2021-05-13 2023-03-21 柳州东风容泰化工股份有限公司 一种氟尿嘧啶的制备纯度评估方法及系统
WO2024054627A1 (en) * 2022-09-08 2024-03-14 The University Of North Carolina At Chapel Hill Diagnosis of patient tumor tissue

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0891550A1 (en) * 1996-04-05 1999-01-20 The Johns Hopkins University School Of Medicine A method of enriching rare cells
US6077684A (en) * 1996-11-14 2000-06-20 Vanderbilt University Automated assay for measuring apoptosis in cell culture
AU2002239491A1 (en) * 2000-11-09 2002-05-27 Vanderbilt University Methods for the treatment of cancer and other diseases and methods of developing the same
KR100721927B1 (ko) * 2006-10-31 2007-05-28 이수앱지스 주식회사 암조직에서 암세포를 분리하는 방법
IT1391619B1 (it) * 2008-11-04 2012-01-11 Silicon Biosystems Spa Metodo per l'individuazione, selezione e analisi di cellule tumorali
BR112012024619A2 (pt) * 2010-03-31 2016-05-31 Diatech Oncology Llc sistema e método para avaliação de candidato a medicamento anticancer
US20110244503A1 (en) * 2010-03-31 2011-10-06 Perree Mathieu System and Method for Anti-Cancer Drug Candidate Evaluation
US9476871B2 (en) * 2012-05-02 2016-10-25 Diatech Oncology Llc System and method for automated determination of the relative effectiveness of anti-cancer drug candidates

Also Published As

Publication number Publication date
IN2014DN09582A (pt) 2015-07-17
IL235709A0 (en) 2015-01-29
CA2873180A1 (en) 2013-11-21
CN104704368A (zh) 2015-06-10
TW201409029A (zh) 2014-03-01
AU2013263337A1 (en) 2014-12-04
MX2014013939A (es) 2015-05-11
EP2850434A1 (en) 2015-03-25
WO2013172955A9 (en) 2014-02-27
SG11201407497TA (en) 2014-12-30
JP2015517662A (ja) 2015-06-22
HK1208727A1 (en) 2016-03-11
CO7240391A2 (es) 2015-04-17
EP2850434A4 (en) 2016-01-13
US20170336391A1 (en) 2017-11-23
US20150160193A1 (en) 2015-06-11
WO2013172955A1 (en) 2013-11-21
KR20150035537A (ko) 2015-04-06
CR20140575A (es) 2015-05-07

Similar Documents

Publication Publication Date Title
BR112014028396A2 (pt) processo de isolamento/purificação de célula de tumor e métodos para uso da mesma
BR112014032105A2 (pt) método para o tratamento de câncer
BR112014016732A2 (pt) processos para tratar lama vermelha
BR112015005749A2 (pt) sitema e método para produzir cosméticos
ES2963732T3 (es) Método de transfección de células
BR112013020540A2 (pt) métodos para preparação de conjugados
BR112014010412A2 (pt) método e disposição para estabilização de veículo
BR112014009302A2 (pt) processo para preparar derivativos de quinolina
CO6890100A2 (es) Tratamientos de combinación para hepatitis c
BR112014010411A2 (pt) método e disposição para estabilização de veículo
DK2723947T3 (da) Centreringssystem
BR112014028424A2 (pt) compostos de pirimidina para o tratamento de câncer
CO6920293A2 (es) Compuestos antibaterianos y método para su uso
BR112015008113A2 (pt) novo processo para preparar compostos para uso no tratamento de câncer.
BR112013034055A2 (pt) alcaftadina para uso no tratamento de urticária
BR112014008203A2 (pt) métodos e sistemas para identificação e tratamento de tumores sensíveis á antiprogestina
BR112014009684A2 (pt) processo para preparar polímeros, polímero e uso de polímeros
BR112013022523A2 (pt) uso de glicopirrolato para o tratamento de taquicardia
BR112015002592A2 (pt) aparelho e processo para dessanilização de água
BR112014022694A2 (pt) novos métodos e composições para o tratamento de doença
BR112012000085A2 (pt) sistema para tratamento biológico
BR112014029487A2 (pt) método para o tratamento cosmético
BR112015000987A2 (pt) processo para a preparação de 5-fluoro-1h-pirazóis
BR112013028890A2 (pt) composições e métodos para o tratamento de câncer
BR112013032651A2 (pt) processo para secagem de dispersantes de concreto

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2474 DE 05-06-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.